{{Rsnum
|rsid=1039302
|Gene=SPPL3
|Chromosome=12
|position=120798455
|Orientation=plus
|GMAF=0.3003
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SPPL3
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 68.1 | 31.0 | 0.9
| HCB | 33.6 | 42.3 | 24.1
| JPT | 47.8 | 44.2 | 8.0
| YRI | 26.7 | 50.0 | 23.3
| ASW | 26.4 | 47.2 | 26.4
| CHB | 33.6 | 42.3 | 24.1
| CHD | 33.0 | 55.0 | 11.9
| GIH | 52.5 | 37.6 | 9.9
| LWK | 33.9 | 50.5 | 15.6
| MEX | 67.2 | 25.9 | 6.9
| MKK | 0.0 | 0.0 | 0.0
| TSI | 75.5 | 21.6 | 2.9
| HapMapRevision=28
}}
{{PMID Auto GWAS
|PMID=19197348
|Trait=Quantitative traits
|Title=Genome-wide association studies in an isolated founder population from the Pacific Island of Kosrae
|RiskAllele=T
|Pval=0.000005
|OR=0.21
|ORtxt=[NR] mg/L increase
|OA=1
}}

C-reactive protein ([[CRP]]) levels being the quantitative trait associated with in {{PMID|19197348|OA=1
}}

{{PMID Auto
|PMID=18978678
|Title=Candidate gene/loci studies in cleft lip/palate and dental anomalies finds novel susceptibility genes for clefts.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1039302
|overall_frequency_n=35
|overall_frequency_d=128
|overall_frequency=0.273438
|n_genomes=22
|n_genomes_annotated=0
|n_haplomes=26
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}